ангиотензин转化酶的古典和非古典效应:增加的 ACE 如何增强骨髓细胞免疫功能
Kenneth E Bernstein1, DuoYao Cao2, Tomohiro Shibata3
1Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA; Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
The Journal of biological chemistry
|May 19, 2024
概括
ангиотензин转化酶 (ACE) 在免疫细胞中具有非经典的作用,促进新陈代谢和抗病能力. 准这种未知的ACE激活分子可能会提供新的治疗途径.
科学领域:
- 免疫学 免疫学 免疫学
- 生物化学 生物化学
- 代谢医学是一种代谢医学.
背景情况:
- 氨酸- ангиотензин系统通常涉及 ангиотензин转化酶 (ACE),产生 ангиотензин II,影响心血管功能,炎症和增殖.
- ACE还表现出非经典的功能,由巨细胞和中性粒细胞等免疫细胞产生的,影响髓状细胞活动,独立于血管新生II.
研究的目的:
- 探索ACE在免疫细胞中的非经典功能及其治疗潜力.
- 研究骨髓状细胞中ACE表达增加的代谢和功能后果.
主要方法:
- 使用了基因改造的小鼠模型 (ACE 10/10和NeuACE),分别在巨细胞和中性粒细胞中增强了ACE表达.
- 评估疾病耐药性 (瘤,感染,动脉样硬化,阿尔茨海默氏症) 和髓状细胞代谢 (氧化代谢,ATP水平,PPARα表达).
- 研究了ACE在精子功能和受精中的作用.
主要成果:
- 增加巨细胞ACE (ACE 10/10) 的小鼠对瘤,感染,动脉样硬化和阿尔茨海默病模型表现出抵抗力.
- 增加中性粒细胞ACE (NeuACE) 的小鼠对感染更具抵抗力;ACE抑制剂降低了细菌的杀死.
- 增强的ACE表达增加了巨细胞的氧化代谢,脂质氧化和ATP水平,与PPARα上调相关.
结论:
- 非经典的ACE功能,独立于血管新生素II,通过未知的介质深刻改变髓状细胞的新陈代谢和功能.
- 针对这种新型的ACE介导途径,为各种疾病提供了潜在的治疗策略.
- 对这种的进一步研究可能会导致有利可图的治疗选择.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
618
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
618
Antihypertensive Drugs: Direct Renin Inhibitors
597
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
597
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Antihypertensive Drugs: Angiotensin II Receptor Blockers
714
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
714


